Bayer Healthcare Llc - Feb 8, 2024 Form 3 Insider Report for Metagenomi, Inc. (MGX)

Role: 10%+ Owner
Signature: Bayer HealthCare LLC, By:/s/ Priyal Patel, Name: Priyal Patel, Title: Treasurer
Stock symbol: MGX
Transactions as of: Feb 8, 2024
Transactions value $: $0
Form type: 3
Date filed: 2/15/2024, 05:03 PM
Previous filing: Jul 24, 2023
Next filing: Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MGX	Series A-1 Convertible Preferred Stock							Feb 8, 2024	Common Stock	1.77M		Direct	F1, F2
holding	MGX	Series A-4 Convertible Preferred Stock							Feb 8, 2024	Common Stock	1.18M		Direct	F2, F3
holding	MGX	Series B Convertible Preferred Stock							Feb 8, 2024	Common Stock	590K		Direct	F2, F4
holding	MGX	Series B-1 Convertible Preferred Stock							Feb 8, 2024	Common Stock	510K		Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's Initial Public Offering ("IPO"). Each share of Series A-1 Convertible Preferred Stock has no expiration date.
F2	The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is controlled by Bayer US Holding LP ("BUSH LP"), a Delaware limited partnership. Bayer World Investments B.V. ("BWI"), a Dutch private limited company, is the general partner of BUSH LP. BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC.
F3	Each share of Series A-4 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series A-4 Convertible Preferred Stock has no expiration date.
F4	Each share of Series B Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B Convertible Preferred Stock has no expiration date.
F5	Each share of Series B-1 Convertible Preferred Stock will automatically convert into shares of common stock upon the closing of the Issuer's IPO. Each share of Series B-1 Convertible Preferred Stock has no expiration date.